The third’s a charm. The fact that Nader is not

The third’s a charm. The fact that Nader is not rushing re-submitting the BLA is that this time they will cross all the “t”s and dot the “i”s and maybe even ask the FDA for their opinion á la EUA before formal submission. NP knows he’s doing his already tarnished reputation no favors by getting another RTF. He’s just not going to risk it.